64 results
8-K
EX-99.1
nida00 1a5aq
5 Aug 20
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
1wjxz6lac
7 May 20
Results of Operations and Financial Condition
7:00am
PRE 14A
4p35y1n f8h11bza4
19 Mar 20
Preliminary proxy
4:19pm
6-K
EX-99.1
ts9q79
7 Jun 17
Live Filing
12:00am
6-K
EX-99.1
el9h95frqi xq46tjet
30 Sep 15
IMPORTANT NEW DATA FROM TEVA’S TEV-48125 PHASE 2b MIGRAINE PROGRAM PUBLISHED INLANCET NEUROLOGYIN BACK-TO-BACK ARTICLES
12:00am
6-K
qrpim8e5c0d41ufsoy
28 Sep 15
Teva Presents New Reslizumab Data at European Respiratory Society (ERS) International Congress 2015
12:00am